Status:
WITHDRAWN
Lean Diabetes Study
Lead Sponsor:
Leon Fogelfeld MD
Conditions:
Lean Diabetes Mellitus
Eligibility:
All Genders
20+ years
Brief Summary
Systematic assessment of perinatal, behavioral and genetic risk factors will be evaluated in an underserved population with lean diabetes (LDM) as compared to a control population with obese type 2 di...
Detailed Description
Background: The prevalence of lean (BMI \<25, non-type 1) diabetes (LDM) is not rare; however, the reason why these individuals develop diabetes without traditional risk factors is often not investig...
Eligibility Criteria
Inclusion
- Cases: BMI \<25 with diabetes, not having exclusion criteria Controls: BMI \>29 with diabetes, not having exclusion criteria
Exclusion
- individuals \<20 years of age, currently pregnant or undergoing chemotherapy, those on glucocorticoid therapy; history of bariatric surgery or pancreatitis; known positive antipancreatic antibodies; individuals with a BMI between 25.0-29.9, A1c \>10%
Key Trial Info
Start Date :
March 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 26 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05407831
Start Date
March 15 2022
End Date
July 26 2023
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cook County Health
Chicago, Illinois, United States, 60612